Shepherd Therapeutics

Rare Cancer is All We Do

SHEPHERD is on an undying mission to save the lives of rare cancer patients.
We serve the left out, the neglected, and the overlooked.

IF NOT US, THEN WHO?

“Rare Cancers” are the third leading cause of death in the U.S. and account for 30 percent of all cancer diagnoses. There are at least 374 known types of rare cancer, which account for more than 500,000 diagnoses every year.

  • 3rd

    leading cause of death in
    U.S. taken
    in aggregate.

  • 30%

    of all cancer
    diagnoses are
    considered rare.

  • 374+

    known types of rare
    cancer.

Rare Cancer statistics based on American Cancer Society's criteria of less than 6 patients per 100,000 incidence rate and as per research presented in American Academy of Cancer Research Abstract 7739.

SHEPHERD CAN HELP MATCH ANY DRUG WITH THE RARE CANCERS IN WHICH IT WILL POTENTIALLY WORK BEST.

Every Life Affected
by Rare Cancer is a Life
Worth fighting for

EVERY LIFE AFFECTED
BY RARE CANCER IS A LIFE
WORTH FIGHTING FOR

EVERY LIFE AFFECTED
BY RARE CANCER IS A LIFE
WORTH FIGHTING FOR

IN THE LIFETIME OF AN AVERAGE AMERICAN:

  • 270 Million

    Americans will be diagnosed with cancer.

  • 47%

    will be under the age of 65.

  • 126 Million

    of those patients will die.

Based on facts and trends as published in the AACR’s Annual Cancer Report, 2017 1.7M diagnoses in 2017; an average increase of ~46,000/year; extrapolated over 78 years = 270 million